Increasing data indicate that these factors play important roles in the E2-dependent cellular proliferation of breast cancer cells [82], [83].
Increasing data indicate that most DUBs/DUBLs regulate a limited number of specific substrates, where they interact either directly with ubiquitin/UBLp, or with the target protein to which ubiquitin/UBLp is conjugated.
Increasing data indicate that the treatment response to chemoradiation associated with the oncologic outcomes [ 28].
On the other hand, increasing data indicate that lncRNAs play an important role in the processes involved in bone and cartilage development [ 7].
In plants, increasing data indicate that sORFs play diverse roles in regulating expression and in this way participate in various cellular processes [ 39].
Increasing data indicate that basal-like breast cancer originates from mammary luminal progenitors [ 43]. p130Cas/BCAR1 up-regulation is sufficient to confer basal cell features on luminal progenitors and to impair their full maturation in response to lactogenic stimuli.
The clinical relevance of iron excess in these disorders, in terms of fibrosis development and cancer risk, is actively debated, but increasing data indicate that iron may sustain disease activity and/or contribute to its progression.
While increasing data indicate the presence of functional heterogeneity within T-ISC enriched populations in other tumours (Hermann et al, 2007; Lee et al, ; Pang et al, 2010; Yang et al, 2008), identification and characterization of mammary T-ISC subsets that consistently metastasize or that mediate therapy resistance presents a challenge.
The rationale for this study was the increasing amount of data indicating that the maternal intestinal microbiota in pregnancy influences the foetal and infant immune system development [ 35].
These findings add to the increasing volume of data indicating that modes of ventilation that provide proportional assistance to ventilation – e.g., NAVA and Proportional Assist Ventilation (PAV) – markedly reduce asynchrony [ 15– 15].
